Valuation: Tofflon Science and Technology Group Co., Ltd.

Market Cap 894.76Cr 132.15Cr 116.06Cr 107.94Cr 99Cr 186.1Cr 13TCr 188.97Cr 1.28TCr 500.75Cr 6.26TCr 496.07Cr 485.38Cr 22TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 553.28Cr 82Cr 72Cr 67Cr 61Cr 115.08Cr 7.87TCr 116.85Cr 792.56Cr 309.64Cr 3.87TCr 306.75Cr 300.14Cr 13TCr EV / Sales 2026 *
0.98x
EV / Sales 2027 * 1.25x
Free-Float
25.51%
Yield 2026 *
1.11%
Yield 2027 * 1.87%
26/05 Tofflon Science and Technology Group Co., Ltd. Announces 2025 Final Profit Distribution Plan on A Shares, Payable on June 1, 2026 CI
28/04 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
28/04 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/25/28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
17/25/17 Tofflon Science and Technology Group Co., Ltd. Approves Interim Cash Dividend on A Shares for the Year 2025, Payable on September 25, 2025 CI
29/25/29 Tofflon Science and Technology Group Co., Ltd. Proposes Interim Cash Dividend for the Year 2025 CI
27/25/27 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
13/25/13 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component A Share Index CI
13/25/13 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component Index CI
22/25/22 Tofflon Science and Technology Group Co., Ltd. Approves Cash Dividend on Share A for 2024 CI
26/25/26 Tofflon Science and Technology Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024 CI
24/25/24 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
24/25/24 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
1 day-0.34%
1 week+0.68%
Current month+6.33%
1 month+4.53%
3 months-15.76%
6 months-33.97%
Current year-25.10%
1 week 11.42
Extreme 11.42
12.25
1 month 10.42
Extreme 10.42
12.71
Current year 10.42
Extreme 10.42
20.37
1 year 10.42
Extreme 10.42
20.37
3 years 9.6
Extreme 9.6
22.28
5 years 9.6
Extreme 9.6
68
10 years 5.16
Extreme 5.16
68
Manager TitleAgeSince
Chief Executive Officer 62 01/01/1993
Director of Finance/CFO 45 01/07/2012
Corporate Officer/Principal 57 01/01/2001
Director TitleAgeSince
Chairman 62 01/03/2008
Director/Board Member 54 30/03/2008
Director/Board Member 53 30/03/2008
Date Insider Type Main position Quantity % Market Cap.
05/02/24 Buy

Chief Executive Officer

40,000 0.0072%
01/02/24 Buy

Chief Executive Officer

30,000 0.0054%
17/01/24 Buy

Chief Executive Officer

80,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+0.68%-17.47%-45.76% 132.15Cr
+0.21%+3.60%+33.66%+148.07% 12TCr
-4.53%-0.20%+56.97%+38.93% 3.78TCr
+0.11%+2.63%-4.38%+29.71% 3.3TCr
-2.95%-0.16%+33.86%+51.60% 2.99TCr
+2.46%-2.47%-9.67%+4.72% 2.85TCr
-2.73%+2.51%+31.77%-4.88% 2.73TCr
+2.22%-5.59%+8.42%+38.01% 2.72TCr
-1.37%-6.68%+712.04%+1,781.40% 2.46TCr
-0.38%+2.68%+35.74%+48.98% 2.45TCr
Average -0.73%+0.80%+88.09%+209.08% 3.59TCr
Weighted average by Cap. -0.60%+1.66%+73.70%+191.04%

Financials

2026 *2027 *
Net sales 567.39Cr 84Cr 74Cr 68Cr 63Cr 118.01Cr 8.07TCr 119.83Cr 812.78Cr 317.54Cr 3.97TCr 314.58Cr 307.8Cr 14TCr 623.82Cr 92Cr 81Cr 75Cr 69Cr 129.75Cr 8.87TCr 131.75Cr 893.61Cr 349.12Cr 4.36TCr 345.86Cr 338.41Cr 15TCr
Net income - -
Net Debt -341.48Cr -50Cr -44Cr -41Cr -38Cr -71Cr -4.86TCr -72Cr -489.16Cr -191.11Cr -2.39TCr -189.32Cr -185.24Cr -8.26TCr -114.86Cr -17Cr -15Cr -14Cr -13Cr -24Cr -1.63TCr -24Cr -164.53Cr -64Cr -803.11Cr -64Cr -62Cr -2.78TCr
Logo Tofflon Science and Technology Group Co., Ltd.
Tofflon Science and Technology Group Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of pharmaceutical equipment, and the provision of technical services. The Company mainly operates four businesses. The bioprocessing business mainly provides equipment, instruments, and consumables such as fermentation systems, precision packaging systems, and traditional Chinese medicine extraction systems. The pharmaceutical preparations business mainly provides equipment and instruments required for the preparation of injectable dosage forms, oral solid dosage forms, and the inspection and packaging of finished drugs. The integrated engineering solutions business mainly provides information system software and intelligent manufacturing integrated solutions. The food engineering business is mainly engaged in the manufacturing of equipment for the liquid food sector, and the provision of system solutions, process engineering, and overall solutions.
Employees
5,479
Date Price Change Volume
24/26/24 CN¥11.76 -0.34% 1,36,84,711
23/26/23 CN¥11.80 +0.85% 99,77,583
22/26/22 CN¥11.70 -1.93% 1,19,65,239
21/26/21 CN¥11.93 -0.17% 1,21,40,536
20/26/20 CN¥11.95 +2.31% 1,31,77,894
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
11.76CNY
Average target price
17.00CNY
Spread / Average Target
+44.56%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300171 Stock